BRUNO, LUCIA PIA
 Distribuzione geografica
Continente #
EU - Europa 148
AS - Asia 119
NA - Nord America 68
SA - Sud America 8
AF - Africa 1
OC - Oceania 1
Totale 345
Nazione #
US - Stati Uniti d'America 68
RU - Federazione Russa 53
HK - Hong Kong 47
IT - Italia 45
SG - Singapore 45
SE - Svezia 23
ID - Indonesia 22
DE - Germania 12
AT - Austria 8
BR - Brasile 8
NL - Olanda 4
CN - Cina 3
UA - Ucraina 2
FR - Francia 1
IN - India 1
NZ - Nuova Zelanda 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 345
Città #
Hong Kong 46
Singapore 37
Santa Clara 33
Milan 24
Jakarta 22
Berlin 3
Moscow 3
Nuremberg 3
Seattle 3
Beijing 2
Mugnano di Napoli 2
Rome 2
Vienna 2
West Jordan 2
Ashburn 1
Belo Horizonte 1
Christchurch 1
Criciúma 1
Delhi 1
Florianópolis 1
Itapecerica da Serra 1
Los Angeles 1
Manila 1
Melzo 1
Pedro Leopoldo 1
Porto Velho 1
Rondonópolis 1
Seriate 1
Sesto San Giovanni 1
Shanghai 1
Springfield 1
São Paulo 1
Totale 202
Nome #
Exome Sequencing in 200 Intellectual Disability/Autistic Patients: New Candidates and Atypical Presentations 42
CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD 40
Identification of a Novel Pathogenic Variant in the NAGLU Gene in a Child with Neurodevelopmental Delay 38
The neurodevelopmental and facial phenotype in individuals with a TRIP12 variant 33
Patient preferences in genetic newborn screening for rare diseases: study protocol 32
Expanding the clinical spectrum associated with the PACS1 p.Arg203Trp mutational hot-spot: Two additional Italian patients 32
Natural history of KBG syndrome in a large European cohort 30
New Candidates for Autism/Intellectual Disability Identified by Whole-Exome Sequencing 30
Exome sequencing in BRCA1-2 candidate familias: the contribution of other cancer susceptibility genes 28
SPTBN5, Encoding the βV-Spectrin Protein, Leads to a Syndrome of Intellectual Disability, Developmental Delay, and Seizures 27
Corrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes (Front. Oncol., (2021), 11, 10.3389/fonc.2021.649435) 26
Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals 23
Totale 381
Categoria #
all - tutte 2.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202461 0 0 0 0 0 0 0 0 37 5 7 12
2024/2025320 14 41 30 16 31 55 36 16 18 63 0 0
Totale 381